Aluminium
Ingredients
Aluminum Adjuvant in Vaccines Causes
Risk to Children According to New Journal Report
A new Canadian study of the mechanisms of aluminum adjuvant toxicity in
pediatric patients confirms that immune challenges during early development,
including those vaccine-induced, can lead to permanent detrimental alterations
of the brain and immune system function. Lucija Tomljenovic, PhD and Christopher
A. Shaw, PhD of the University of British Columbia’s evidence-based study was
recently published in Lupus, the only fully peer reviewed international journal
devoted exclusively to lupus (and related autoimmune disease) research.
<
http://www.prweb.com/releases/2012/1/prweb9146755.htm>
New York, NY (PRWEB) January 29, 2012
A new Canadian study of the mechanisms of aluminum adjuvant toxicity in
pediatric patients confirms that immune challenges during early development,
including those vaccine-induced, can lead to permanent detrimental alterations
of the brain and immune system function. Lucija Tomljenovic, PhD and Christopher
A. Shaw, PhD of the University of British Columbia’s evidence-based study was
recently published in Lupus, the only fully peer reviewed international journal
devoted exclusively to lupus (and related disease) research.
Tomljenovic L, Shaw CA. Mechanisms of aluminum adjuvant toxicity in pediatric
populations.
Lupus. 2011;21(2):223-230
Summary
Immune challenges during early development, including those vaccine-induced, can
lead to permanent detrimental alterations of the brain and immune system
function. Experimental evidence also shows that simultaneous administration of
as little as two to three immune adjuvants can overcome genetic resistance to
autoimmunity. In some developed countries, by the time children are 4 to 6 years
old, they will have received a total of 126 antigenic compounds along with high
amounts of aluminum (Al) adjuvants through routine vaccinations. According to
the US Food and Drug Administration, safety assessments for vaccines have often
not included appropriate toxicity studies because vaccines have not been viewed
as inherently toxic.
Taken together, these observations raise plausible concerns about the overall
safety of current childhood vaccination programs.
When assessing adjuvant toxicity in children, several key points ought to be
considered:
1) During prenatal and early postnatal development the brain is extremely
vulnerable to neurotoxic insults;
2) Aluminum is a neurotoxin and a strong immune stimulant. Hence, aluminum
has all the necessary biochemical properties to induce neuro-immune diseases.
Autism is one such disease. Namely, autism is characterized by dysfunctional
immunity and abnormalities in brain function;
3) In adult humans aluminum vaccine adjuvants have been linked to a variety
of serious autoimmune and inflammatory conditions, yet children are regularly
exposed to much higher amounts of aluminium from vaccines than adults;
4) It is often incorrectly assumed that peripheral immune challenges
(analogous to vaccinations) do not affect brain function. However, it is now
clearly established that there is a cross-talk between the nervous and the
immune system. It is also demonstrated that this cross-talk plays a crucial role
in both immunoregulation as well as brain function. In turn, perturbations of
the neuro-immune regulatory system have been demonstrated in many autoimmune
diseases and are thought to be driven by a hyperactive immune response;
5) The same components of the neuro-immune regulatory system that have key
roles in both brain development and immune function are heavily affected by
aluminum adjuvants;
In summary, research evidence shows that increasing concerns about current
vaccination practices may indeed be warranted. Because children may be most at
risk of vaccine-induced complications, a rigorous evaluation of the
vaccine-related adverse health impacts in the pediatric population is urgently
needed.
Study abstract here
<
http://www.ncbi.nlm.nih.gov/pubmed/22235057>
very good presentation of the study here- fulltext of the study is not available
to the public
<
http://gaia-health.com/gaia-blog/2012-01-14/mechanisms-of-aluminimum-adjuvant-revealed-vaccine-risks-to-children-clarified/
>